Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Adrenodoxin mitochondrial | 0.0112 | 0.0273 | 1 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase small chain CoxS | 0.0665 | 0.1868 | 0.2519 |
Wolbachia endosymbiont of Brugia malayi | ferredoxin | 0.0112 | 0.0273 | 0.5 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase medium chain CoxM | 0.1177 | 0.3343 | 0.4847 |
Echinococcus multilocularis | Adrenodoxin, mitochondrial | 0.0112 | 0.0273 | 1 |
Trypanosoma cruzi | adrenodoxin precursor, putative | 0.0112 | 0.0273 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0044 | 0.1193 |
Leishmania major | adrenodoxin-like protein,ferredoxin, 2fe-2s-like protein | 0.0112 | 0.0273 | 0.5 |
Leishmania major | adrenodoxin-like protein,ferredoxin, 2fe-2s-like protein | 0.0112 | 0.0273 | 0.5 |
Trichomonas vaginalis | aldehyde oxidase, putative | 0.3486 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0044 | 0.1193 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.1643 | 0.4688 | 0.6971 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0112 | 0.0273 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0044 | 0.1193 |
Trypanosoma brucei | NADH-ubiquinone oxidoreductase complex I subunit, putative | 0.0112 | 0.0273 | 0.5 |
Chlamydia trachomatis | Na(+)-translocating NADH-quinone reductase subunit F | 0.0112 | 0.0273 | 0.5 |
Toxoplasma gondii | adrenodoxin-type ferredoxin, putative | 0.0112 | 0.0273 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0567 | 0.1583 | 0.2069 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0365 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0042 | 0.1146 |
Trypanosoma cruzi | adrenodoxin precursor, putative | 0.0112 | 0.0273 | 0.5 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.1033 | 0.2929 | 0.4193 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0044 | 0.1193 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0365 | 1 |
Onchocerca volvulus | Adrenodoxin, mitochondrial homolog | 0.0112 | 0.0273 | 1 |
Toxoplasma gondii | ferodoxin FD | 0.0112 | 0.0273 | 0.5 |
Giardia lamblia | [2Fe-2S] ferredoxin | 0.0112 | 0.0273 | 0.5 |
Plasmodium vivax | ferredoxin, putative | 0.0112 | 0.0273 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0044 | 0.1193 |
Chlamydia trachomatis | ferredoxin | 0.0112 | 0.0273 | 0.5 |
Leishmania major | ferredoxin 2fe-2s-like protein | 0.0112 | 0.0273 | 0.5 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 | 0.1177 | 0.3343 | 0.4847 |
Echinococcus multilocularis | ferredoxin adrenodoxin | 0.0112 | 0.0273 | 1 |
Plasmodium falciparum | adrenodoxin-type ferredoxin, putative | 0.0112 | 0.0273 | 0.5 |
Treponema pallidum | hypothetical protein | 0.0567 | 0.1583 | 1 |
Leishmania major | ferredoxin, 2fe-2s-like protein | 0.0112 | 0.0273 | 0.5 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 | 0.1643 | 0.4688 | 0.6971 |
Loa Loa (eye worm) | 2Fe-2S iron-sulfur cluster binding domain-containing protein | 0.0112 | 0.0273 | 0.7466 |
Mycobacterium ulcerans | carbon monoxide dehydrogenase | 0.2309 | 0.6607 | 1 |
Echinococcus granulosus | ferredoxin | 0.0112 | 0.0273 | 1 |
Onchocerca volvulus | 0.0112 | 0.0273 | 1 | |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0365 | 1 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase small chain CoxS | 0.0665 | 0.1868 | 0.2519 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (small chain) | 0.0665 | 0.1868 | 0.3614 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.3486 | 1 | 1 |
Brugia malayi | Adrenodoxin-like protein, mitochondrial precursor, putative | 0.0112 | 0.0273 | 0.7466 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (large chain) | 0.1643 | 0.4688 | 1 |
Trypanosoma brucei | electron transfer protein, putative | 0.0112 | 0.0273 | 0.5 |
Trypanosoma cruzi | adrenodoxin precursor, putative | 0.0112 | 0.0273 | 0.5 |
Schistosoma mansoni | adrenodoxin | 0.0112 | 0.0273 | 1 |
Treponema pallidum | quinoline 2-oxidoreductase | 0.0553 | 0.1545 | 0.8682 |
Toxoplasma gondii | ferredoxin, putative | 0.0112 | 0.0273 | 0.5 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (medium chain) | 0.1177 | 0.3343 | 0.6953 |
Plasmodium falciparum | ferredoxin, putative | 0.0112 | 0.0273 | 0.5 |
Brugia malayi | 2Fe-2S iron-sulfur cluster binding domain containing protein | 0.0112 | 0.0273 | 0.7466 |
Schistosoma mansoni | adrenodoxin | 0.0112 | 0.0273 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0112 | 0.0273 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0891 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.